Idexx Laboratories (IDXX) Net Margin (2009 - 2026)

Idexx Laboratories (IDXX) has reported Net Margin for 18 consecutive years, with 24.41% the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Margin rose 10.0% year-over-year to 24.41%; the TTM figure through Mar 2026 stood at 24.63% (up 187.0% YoY), while the FY2025 annual figure was 24.62%, up 184.0% from the prior year.
• Net Margin came in at 24.41% for Q1 2026 at Idexx Laboratories, up from 22.76% in the prior quarter.
• The five-year high for Net Margin was 26.5% in Q2 2025, with the low at 15.34% in Q2 2022.
• Average Net Margin over 5 years is 22.77%, with a median of 23.19% recorded in 2022.
• Across the five-year window, Net Margin tumbled 910 bps in 2022 and soared 843 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 20.78% in 2022, then gained by 4 bps to 21.58% in 2023, then increased by 5 bps to 22.65% in 2024, then climbed by 0 bps to 22.76% in 2025, then increased by 7 bps to 24.41% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 24.41%, 22.76%, and 24.85% for Q1 2026, Q4 2025, and Q3 2025 respectively.